| 48 hours (113) | 7 days (87) | 14 days (38) | 21 days (19) | 30 days (17) | 50 days (7) | p-value | |
|---|---|---|---|---|---|---|---|
| Age (Years) | 52.5±15.8 | 53.7±15.3 | 52.6±17.0 | 52.5±12.0 | 49.7±14.3 | 52.1±14.0 | 0.957 |
| Sex (M:F) | 63:50 | 50:37 | 20:18 | 14:5 | 11:6 | 6:1 | 0.085 |
| Affected ear (R:L) | 48:65 | 44:43 | 14:24 | 9:10 | 5:12 | 5:2 | 0.962 |
| Duration from onset to treatment | 1.2±0.7 | 4.6±1.4 | 11.0±2.4 | 17.3±2.3 | 27.0±4.1 | 47.2±5.2 | <0.001 |
| PTA (dB) | 82.2±28.8 | 75.1±26.5 | 76.6±24.2 | 75.4±24.1 | 52.0±35.8 | 49.3±37.6 | <0.001 |
| WRS (%) | 28.4±38.4 | 28.5±37.4 | 30.7±35.9 | 36.1±33.5 | 52.9±36.6 | 69.1±42.8 | 0.019 |
| Vertigo | 38 (33.6%) | 23 (26.4%) | 11 (28.9%) | 5 (26.3%) | 4 (25.0%) | 0 ( 0.0%) | 0.119 |
| DM | 26 (23.0%) | 14 (16.1%) | 8 (21.1%) | 0 ( 0.0%) | 0 ( 0.0%) | 3 (42.9%) | 0.139 |
| HTN | 24 (21.2%) | 18 (20.7%) | 13 (34.2%) | 2 (10.5%) | 2 (12.5%) | 2 (28.6%) | 0.868 |
| HL type (LF HL) | 4 ( 3.5%) | 2 ( 2.3%) | 1 ( 2.6%) | 0 ( 0.0%) | 0 ( 0.0%) | 1 (14.3%) | 0.859 |
| post-PTA (dB HL) | 60.8±26.8 | 50.5±30.7 | 63.0±25.1 | 66.8±22.0 | 55.6±31.7 | 52.5±38.5 | 0.064 |
| post-WRS (%) | 49.8±37.0 | 58.6±41.6 | 47.6±37.8 | 43.5±31.6 | 57.2±38.9 | 61.7±41.4 | 0.417 |